Results 251 to 260 of about 1,358,257 (368)

Traditional Chinese medicine therapies for insomnia: an umbrella review and evidence map

Jinxiang Wang, Bing Bai, Ranran Zhu, Xintong Yu, Xiaoting Xu, Xiaomin Tu, Lei Fang   +6 more
openalex   +1 more source

Annual and Analytical Cyclopedia of Practical Medicine.By Chas. E. De M. Sajous and one hundred associate editors, assisted by corresponding editors, collaborators and correspondents. Illustrated with chromolithographs, engravings and maps. Vol. I. Philadelphia, New York, Chicago. The F. A. Davis Company, publishers, 1898 [PDF]

, 1898
H. M. B.
openalex   +1 more source

Endoglin mediates the tumor‐ and metastasis‐promoting traits of stromal myofibroblasts in human breast carcinomas

Molecular Oncology, EarlyView.
Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo, Yoshihiro Mezawa, Zixu Wang, Ahmet Acar, Yasuhiko Ito, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Yataro Daigo, Takuya Shirakihara, Akira Orimo   +11 more
wiley   +1 more source

Application of ultrasound in liver cancer from 2014 to 2024: bibliometric analysis and global trends. [PDF]

Discov Oncol
Zhu Y, Lu Y, Chen X.
europepmc   +1 more source

Author Correction: Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms

Alexander Mazein, Marek Ostaszewski, Inna Kuperstein, Steven Watterson, Nicolas Le Novère, Diane Lefaudeux, Bertrand De Meulder, Johann Pellet, Irina Balaur, Mansoor Saqi, Maria Manuela Nogueira, Feng He, Andrew Parton, Nicolas Lemonnier, Piotr Gawron, Stephan Gebel, Pierre Hainaut, Markus Ollert, Uḡur Doḡrusöz, Emmanuel Barillot, Andreï Zinovyev, Reinhard Schneider, Rudi Balling, Charles Auffray   +23 more
openalex   +1 more source

Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade

Molecular Oncology, EarlyView.
Rolig, Peng, and colleagues have shed new light on how dual blockade of PD1 and LAG3 enhances antitumor immunity. They found that response to immunotherapy with anti‐PD1 + anti‐LAG3 was associated with reprogramming of canonically suppressive CD4+ regulatory T cells to an inflammatory state.
Tullia C. Bruno, Anthony R. Cillo
wiley   +1 more source

Optimizing Vital Signs in Patients With Traumatic Brain Injury: Reinforcement Learning Algorithm Development and Validation.

J Med Internet Res
Zhang H, Diao M, Zhang S, Ni P, Zhang W, Wu C, Zhu Y, Hu W.   +7 more
europepmc   +1 more source

Trends and hotspots in cupping therapy research for pain: a bibliometric study. [PDF]

Front Med (Lausanne)
Xu R, Liu SL, Xu G, Yan C, Cui Q, Liu S, Sun M.   +6 more
europepmc   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source

Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial. [PDF]

Intensive Care Med
Endo A, Yamakawa K, Tagami T, Umemura Y, Wada T, Yamamoto R, Nagasawa H, Takayama W, Yagi M, Takahashi K, Kojima M, Narita C, Kazuma S, Takahashi J, Shiraishi A, Todani M, Nakane M, Nagata T, Tanaka S, Yokokawa Y, Takahashi K, Ishikita H, Hisamune R, Sasaki J, Muramatsu KI, Sonobe H, Minami K, Hoshi H, Otomo Y, OPTPRESS trial investigators.   +29 more
europepmc   +1 more source